Long term follow up of 16 homosexual men and 78 intravenous drug abusers who were chronic carriers of hepatitis B surface antigen (HBsAg) showed fundamental differences between the two groups. Viral replication, expressed by the presence of hepatitis B e antigen, lasted for four years or more in 10 out of 14 (71%) of the homosexual men whereas it was not present in 43 out of 73 (59%) of the drug addicts within one year. This shows a difference in the immunological response between homosexual HBsAg carriers and addicts that is not related to infection with human T cell lymphotropic virus type HI.
Introduction
Hepatitis B virus tends to cause chronic infection, but its long term course differs considerably among different groups known to be at risk of infection. In this study all chronic carriers of hepatitis B surface antigen (HBsAg) registered during 1970-84 were followed up and two particular risk groups-namely, intravenous drug abusers and homosexual men-were compared in terms of clinical findings, length of viral replication as expressed by the presence of hepatitis B e antigen (HBeAg), and degree of histological damage as shown by liver biopsy.
Subjects and methods
The patients were taken from a consecutive series of patients with acute and chronic hepatitis B seen mainly at the department of infectious diseases at Malmo General Hospital, Sweden, during 1970-84 (population of Malmo 230 000). This is the only hospital in the city that receives patients with hepatitis. A few patients were seen in the prison hospital only, sometimes referred from prisons elsewhere in Sweden.
A total of 239 chronic HBsAg carriers (men:women 4-5:1) were registered, 78 of whom were drug addicts (men:women 6-8:1) and 16 homosexual men. The addicts were followed up for one to 13 (mean [5] [6] [7] [8] years and the homosexual men for one to nine (4 2) years. Age at first contact was 16-53 (24-2) in the addicts and 22-64 (34 4) in the homosexual men. These patients were seen initially in various circumstances. One group sought medical attention for symptoms of acute disease. Others were seen during evaluation of diseases other than hepatitis; as a result of routine preventive medicine, and dentistry; or during screening for potential sources of infection. All were advised to join a follow up programme with monthly, half yearly, and yearly visits. The purpose was to evaluate chronicity and prevent secondary cases by information and prophylaxis-for example, with hyperimmune globulin and, more recently, vaccine. Attendance was fully satisfactory only in the homosexual men. Follow up ofthe drug addicts was often difficult. Indeed, some were available only during their repeated spells in prison.
A chronic HBsAg carrier was defined as a subject with HBs antigenaemia for more than six months. In these patients acute hepatitis was diagnosed on the basis of clinical symptoms and signs such as jaundice, nausea, anorexia, upper abdominal pain, pale stools, and dark urine together with a more than 10-fold increase in alanine transaminase activity. If patients were asymptomatic the diagnosis of acute hepatitis was based on laboratory criteria only. The presence of IgM antibodies to the hepatitis B core antigen (anti-HBc IgM) was taken to indicate recent onset of infection. Liver biopsy was carried out according to the technique of Menghini. Most biopsy specimens were obtained by a disposable needle (Hepafix). Generally, the specimens were read by the same pathologist without access to clinical details. Criteria for the diagnosis of chronic hepatitis from biopsy specimens were those of Bianchi et al. 
Results

HOMOSEXUAL MEN
At presentation two patients had acute symptomatic hepatitis. Two other patients, though asymptomatic, had significant increases in enzyme activity (75-fold and 60-fold). In all four the diagnosis of acute hepatitis B was confirmed by the detection of anti-HBc IgM. In the 12 early loss of HBeAg could have been an artefact if the patients had been chronic HBsAg carriers for several years when first seen, the analysis was repeated in those HBsAg carriers in whom it was safe to assume recent onset of carrier state-that is, in patients in-whom analysis of anti-HBc IgM had been carried out and in whom the results were positive (titre above . In 29 such patients loss of HBeAg proceeded at the same rate as in the total group of 78 (table I) .
Markers of delta infection were found in 41 out of 71 (63%) HBsAg carriers seen after the introduction of the delta agent in 1973.3 Anti-HTLV-III was not detected in any drug addict who was an HBsAg carrier.
A total of 31 biopsy examinations were performed in 27 of the 78 carriers (table III) . There were two cases of cirrhosis, in a 48 year old alcoholic dying from haematemesis and melaena (case 22) and in a female drug addict who had been positive for antidelta for six years (case 29). In the last biopsy specimen taken six patients had chronic aggressive and 15 chronic persistent hepatitis. Acute hepatitis was found in two patients; both suffered from acute delta hepatitis (superinfection). In two patients the histological diagnosis was non-specific hepatitis. During follow up of the 78 drug addicts normal enzyme activities were noted on at least one occasion in 25 patients. In 16 it was the final outcome of follow up, in the rest the enzyme activity was raised on following visits. It was not possible to evaluate the role of hepatitis non-A, non-B in these patients.
The carrier state as such caused little physical suffering. There were, however, several intervening episodes of acute hepatitis in the drug addicts. In 19 patients this was superinfection with the delta agent, which often required extended periods in hospital; in four hepatitis A; and in three presumably hepatitis non-A, non-B. Seven men died, one offulminant delta superinfection, three probably from opiate overdoses, two from intestinal bleeding, and one was murdered.
Fourteen patients (18%) lost HBsAg after a mean observation time of five years (range one to eight years). In three the clearance of antigen followed immediately after an acute infection with the delta antigen. Anti-HBs was detected in 11 patients. There was no suggestion of HBsAg being lost when drugs were no longer taken. Of the 78 drug addicts, 51 (65%) were HBeAg positive when first seen. After two years 14 out of 64 (22%) and after five years three out of 44 (7%) addicts had retained HBeAg. As this apparent
In table IV the drug addicts are divided into those with and those without markers of delta infection. The table compares the histological findings of a benign group (patients with acute, chronic lobular, and chronic persistent hepatitis) with those of a severe group (those with chronic aggressive hepatitis, cirrhosis, and primary liver cancer). More than half of the patients who were delta positive were in the severe group, whereas all of the delta negative addicts were in the benign group. This difference is significant at the 0-01 level (X2 test).
Discussion
The benefits of a systematic follow up programme of all chronic HBsAg carriers registered in a certain geographical area indicate that such a programme should be recommended whenever possible. From the files of the programme information may be given This may be related to the reported immunodepressive effect of semen in homosexual recipients. 16 Recently, altered immune responsiveness among homosexual men has been reported by Anderson et al. '7 In discussing the difference in serological response between the two groups, we should consider age and sex. The severity of hepatitis B tends to increase with age. The age difference, however, is small (10 years) and probably has little effect on the serological outcome. Although 10 of the drug addicts were women, no difference in the rate of seroconversion from HBeAg to anti-HBe was seen between the sexes.
Our findings of a limited period of viral replication in drug addicts should serve to reduce the fear of accidental inoculation of hepatitis among hospital staff and others who have regular contact with drug addicts. The number of chronic HBsAg positive drug addicts is considerable, but the number of infectious HBsAg carriers at any given time is small.
Liver biopsy was carried out in roughly one third of the addicts and two thirds of the homosexual men. In view of the lack of symptoms in the homosexual men the findings were surprisingly serious (table II) . Six of 11 HBsAg positive homosexual men had chronic aggressive hepatitis or cirrhosis, or both. In one primary liver cancer developed. These results are comparable with those ofa British report in which 45% of a series of predominantly homosexual HBsAg carriers had either chronic aggressive hepatitis, cirrhosis, or primary liver cancer.5 Interestingly, in seven of our patients who underwent a second biopsy examination deterioration was noted in six.
In the drug addicts serious liver damage was found exclusively in patients with markers of delta infection. Of 14 such patients, eight had chronic aggressive hepatitis, two with cirrhosis. In contrast, all 13 patients without markers of delta infection showed potentially benign changes ( 
Introduction
We recently showed large quantities of histamine in the sputum of patients with chronic bronchitis and cystic fibrosis; concentrations increased substantially when samples were incubated at 37°C. This phenomenon was prevented both by heating samples at 100°C before incubation and by adding antibiotics, suggesting bacterial synthesis of histamine.'I As the experiments did not clearly indicate which species might be responsible we investigated the ability of oirganisms commonly isolated from sputum to s'ynthesise histamine. We report here our findings for Haemophilus influenzae, a common respiratory pathogen. Methods T'he strains ofH influenzae studied included 10 isolates from patients with acute exacerbation of chronic bronchitis and emphysema and reference strains NCTC 8467 Pittman type b and NCTC 7918 Pittman type f (now uncapsulated).. The culture medium used was a modified trypticase soy broth supplemented with histidine (Igf1), pyridoxine (5mg/1), and 5% Fildes' extract (Oxoid Ltd, UK). Each strain was incubated in trypticase soy broth at 370C overnight, and 1 ml of this culture was then added to 20 ml trypticase soy broth in a sterile polypropylene container, which was incubated at 370G for 48 hours with gentle agitation. Samples taken for histamine analysis were stored at -200G.' Histamine was analysed by high. performance -liqulid chromatography. ' Dup'licate cultures of the 12 strains were prepared as above. Histamine concentration wasestimated at 0 and 48 hours a-nd purity plates inoculated to check for contamination. Bacteria were counted at 48 hours. Two broths that had not been inoculated were' indluded as negative controls. To check reproducibility four replicate cultu're's of two isolates found to produce histamine were set up and samples taken at 0, 24, and 48 hours. Duplicate cultures of one strain that produced histamine were also set up as above and samples taken at 0, two, four, six, niine, 12, 24, 31, and 48 hours for histamine analysis and bacterial counts.
Results
Seven o'f the 12 isolates produced histamine, the concentration in the culture -medium increasing in the range 127-3360%/. All replicates showed highly significant increases in histamine concentrations at 24 and 48 hours (p<0-01 and p<0*001 respectively). Controls showed no.increases. The figure shows the relation between bacterial growth and production-of
